A review of 5 investigational therapies with target action dates in November 2026, spanning neurology, gastroenterology, and oncology.
The FDA has approved Hibsago (bepirovirsen) as an add-on antisense oligonucleotide therapy to help noncirrhotic adults with chronic hepatitis B achieve functional cure.
HealthDay News — Benzodiazepine use in pregnancy is not associated with an increased risk for major congenital malformations, according to a study published online October 13 in the Annals of Internal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results